<DOC>
	<DOCNO>NCT01071226</DOCNO>
	<brief_summary>T cell depletion utilize CliniMACS device allow precise , specific control graft engineering peripheral blood stem cell unrelated partially match related donor without increase relapse graft rejection grade III IV acute graft versus host disease ( GVHD ) .</brief_summary>
	<brief_title>Peripheral Blood Stem Cell Transplantation Using CliniMACS Device</brief_title>
	<detailed_description />
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<criteria>All race eligible Malignant disease : Leukemias Lymphomas Nonmalignant diseases : Severe Aplastic Anemia , immunodeficiencies Lansky Karnofsky &gt; 70 Echo &gt; 27 % shorten fraction renal function : serum creatinine &lt; 1.5 x normal age active untreated infection DLCO &gt; 50 % predict value Hepatic : AST ALT &lt; 3x upper limit normal ; bilirubin &lt; 2.0 .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Malignant non-malignant disease</keyword>
	<keyword>Hematopoietic stem cell transplant</keyword>
	<keyword>Peripheral blood progenitor cell transplant</keyword>
	<keyword>CliniMACS device</keyword>
	<keyword>T cell depletion</keyword>
</DOC>